MONICA BOOTH: Open Payments
NPI 1457708638 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$832 in 26 payments from 15 companies in 2025. Trend: 2023 $24 · 2024 $20 · 2025 $832
Food & beverage: $832
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 3 | $171 |
| Janssen Pharmaceuticals, Inc | 1 | $142 |
| Vanda Pharmaceuticals Inc. | 4 | $125 |
| Braeburn Inc. | 4 | $99 |
| Teva Pharmaceuticals USA, Inc. | 2 | $38 |
| Indivior Inc. | 1 | $36 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $32 |
| Neurocrine BioSciences, Inc. | 1 | $31 |
| ABBVIE INC. | 2 | $31 |
| Supernus Pharmaceuticals, Inc. | 1 | $24 |
Products named: LYBALVI, SPRAVATO, FANAPT, BRIXADI, AUSTEDO XR, SUBLOCADE, TRINTELLIX, INGREZZA.
Industry payments across AZ — which companies pay providers there.
